Length of uninterrupted CAG repeats, independent of polyglutamine size, results in increased somatic instability and hastened age of onset in Huntington disease

Huntington disease (HD) is an autosomal dominant neurological disorder that is caused by a CAG repeat expansion, translated into polyglutamine, in the huntingtin (HTT) gene. Although the length of this repeat polymorphism is inversely correlated with age of onset (AOO), it does not fully explain the variability in AOO. Genomic studies have provided evidence for the involvement of DNA repair in modifying this trait, potentially through somatic repeat instability. We therefore assessed genetic variants within the 12bp interrupting sequence between the pathogenic CAG repeat and the polymorphic proline (CCG) tract in the HTT gene and identified variants that result in complete loss of interruption (LOI) between the adjacent CAG/CCG repeats. Analysis of multiple HD pedigrees showed that this variant is associated with dramatically earlier AOO and is particularly relevant to HD patients with reduced penetrance alleles. On average AOO of HD is hastened by an average of 25 years in LOI carriers. This finding indicates that the number of uninterrupted CAG repeats is the most significant contributor to AOO of HD and is more impactful than polyglutamine length, which is not altered in these patients. We show that the LOI variant is associated with increases in both somatic and germline repeat instability, demonstrating a potential mechanism for this effect. Screening individuals from the general population (n=2,674 alleles) suggests that the variant occurs only in expanded CAG repeat alleles. Identification of this modifier has important clinical implications for disease management of HD families, especially for those in the reduced penetrance ranges.

[1]  Enrico Amico,et al.  Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study. , 2017, The Lancet. Neurology.

[2]  Wenya Linda Bi,et al.  Triplet repeat mutation length gains correlate with cell-type specific vulnerability in Huntington disease brain. , 2007, Human molecular genetics.

[3]  M. Hayden,et al.  Huntingtin Haplotypes Provide Prioritized Target Panels for Allele-specific Silencing in Huntington Disease Patients of European Ancestry. , 2015, Molecular therapy : the journal of the American Society of Gene Therapy.

[4]  Suzanne Powell,et al.  Autopsy‐proven Huntington's disease with 29 trinucleotide repeats , 2007, Movement disorders : official journal of the Movement Disorder Society.

[5]  G. van Ommen,et al.  New problems in testing for Huntington's disease: the issue of intermediate and reduced penetrance alleles , 2001, Journal of medical genetics.

[6]  Y. Agid,et al.  Sequence analysis of the CCG polymorphic region adjacent to the CAG triplet repeat of the HD gene in normal and HD chromosomes. , 1995, Journal of medical genetics.

[7]  T. Ashizawa,et al.  An interrupted 34-CAG repeat SCA-2 allele in patients with sporadic spinocerebellar ataxia , 2000, Neurology.

[8]  M. Hayden,et al.  Unstable familial transmissions of Huntington disease alleles with 27–35 CAG repeats (intermediate alleles) , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[9]  Karen Marder,et al.  Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[10]  S. Yu,et al.  Polymorphisms in the CAG repeat – a source of error in Huntington disease DNA testing , 2000, Clinical genetics.

[11]  M. Hayden,et al.  Re: Autopsy‐proven Huntington's disease with 29 trinucleotide repeats , 2008, Movement disorders : official journal of the Movement Disorder Society.

[12]  I. Kanazawa,et al.  SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein. , 2001, Human molecular genetics.

[13]  M. Hayden,et al.  Somatic and gonadal mosaicism of the Huntington disease gene CAG repeat in brain and sperm , 1994, Nature Genetics.

[14]  M. Hegde,et al.  Null alleles at the Huntington disease locus: implications for diagnostics and CAG repeat instability. , 2000, Genetic testing.

[15]  S. Shirato,et al.  Mutations in the TIGR gene in familial primary open-angle glaucoma in Japan. , 1997, American journal of human genetics.

[16]  M. Hayden,et al.  The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size. , 1997, American journal of human genetics.

[17]  David J. Arenillas,et al.  A SNP in the HTT promoter alters NF-κB binding and is a bidirectional genetic modifier of Huntington disease , 2015, Nature Neuroscience.

[18]  Peter Holmans,et al.  The HTT CAG-Expansion Mutation Determines Age at Death but Not Disease Duration in Huntington Disease. , 2016, American journal of human genetics.

[19]  D. Sillence,et al.  Increased instability of intermediate alleles in families with sporadic Huntington disease compared to similar sized intermediate alleles in the general population. , 1995, Human molecular genetics.

[20]  M. Hayden,et al.  CAG size-specific risk estimates for intermediate allele repeat instability in Huntington disease , 2013, Journal of Medical Genetics.

[21]  G. van den Engh,et al.  Contribution of DNA sequence and CAG size to mutation frequencies of intermediate alleles for Huntington disease: evidence from single sperm analyses. , 1997, Human molecular genetics.

[22]  B. Kremer,et al.  Somatic mosaicism in sperm is associated with intergenerational (CAG)n changes in Huntington disease. , 1995, Human molecular genetics.

[23]  M. Hayden,et al.  Huntington disease reduced penetrance alleles occur at high frequency in the general population , 2016, Neurology.

[24]  Chris Shaw,et al.  Detection of long repeat expansions from PCR-free whole-genome sequence data , 2016, bioRxiv.

[25]  S. Tishkoff,et al.  The molecular epidemiology of Huntington disease is related to intermediate allele frequency and haplotype in the general population , 2018, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[26]  Jane S. Paulsen,et al.  Identification of Genetic Factors that Modify Clinical Onset of Huntington’s Disease , 2015, Cell.

[27]  Elizabeth Evans,et al.  Dramatic tissue-specific mutation length increases are an early molecular event in Huntington disease pathogenesis. , 2003, Human molecular genetics.

[28]  C. Broeckhoven,et al.  CAG repeat expansion in the TATA box-binding protein gene causes autosomal dominant cerebellar ataxia. , 2001, Brain : a journal of neurology.

[29]  M. Hayden,et al.  High frequency of intermediate alleles on huntington disease‐associated haplotypes in British Columbia's general population , 2013, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[30]  A. Destée,et al.  Are interrupted SCA2 CAG repeat expansions responsible for parkinsonism? , 2007, Neurology.

[31]  Edith T. Lopez,et al.  Mismatch Repair Genes Mlh1 and Mlh3 Modify CAG Instability in Huntington's Disease Mice: Genome-Wide and Candidate Approaches , 2013, PLoS genetics.

[32]  B. Harper.  Huntington Disease , 2005, Journal of the Royal Society of Medicine.

[33]  Jane S. Paulsen,et al.  A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length , 2004, Clinical genetics.

[34]  M. Hayden,et al.  Marked differences in neurochemistry and aggregates despite similar behavioural and neuropathological features of Huntington disease in the full-length BACHD and YAC128 mice. , 2012, Human molecular genetics.

[35]  B. Frey,et al.  Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder , 2017, Nature Neuroscience.